Stephen Kanes Sage Therapeutics, Inc. (SAGE) insider trading activity

SAGE Quotes by TradingView

Stephen Kanes is Chief Medical Officer of Sage Therapeutics, Inc.. Currently has a direct ownership of 13,471 shares of SAGE, which is worth approximately $69,645. The most recent transaction as insider was on Oct 19, 2021, when has been sold 1,120 shares (Common Stock) at a price of $40.29 per share, resulting in proceeds of $45,125. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.5K
0% 3M change
0% 12M change
Total Value Held $69,645

Stephen Kanes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 19 2021
SELL
Payment of exercise price or tax liability
$45,125 $40.29 p/Share
1,120 Reduced 7.68%
13,471 Common Stock
Oct 19 2021
BUY
Grant, award, or other acquisition
-
3,800 Added 20.66%
14,591 Common Stock
Jun 15 2021
SELL
Payment of exercise price or tax liability
$58,859 $58.8 p/Share
1,001 Reduced 8.49%
10,791 Common Stock
Jun 15 2021
BUY
Grant, award, or other acquisition
-
3,500 Added 22.89%
11,792 Common Stock
SK

Stephen Kanes

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on SAGE

Follow Sage Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SAGE shares.

Notify only if

Insider Trading

Get notified when an Sage Therapeutics, Inc. insider buys or sells SAGE shares.

Notify only if

News

Receive news related to Sage Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SAGE